Physician profile
Eric Beckelman
NPI 1649721465
$442.52
in general payments reported to CMS, 2019-2025
9 companies · $91.40 in 2025
The $91.40 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $115 · 2024: $236 · 2025: $91.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $442.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $92.75 | 2024-2025 | Cardiomems |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $92.42 | 2023-2025 | Lifevest |
| Novo Nordisk INC | $62.62 | 2024 | Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $46.82 | 2023-2024 | |
| Esperion Therapeutics, INC. | $46.82 | 2024 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $39.87 | 2024 | Wainua |
| Philips North America LLC | $24.07 | 2025 | Extended Holter |
| Siemens Medical Solutions USA, INC. | $19.90 | 2024 | Acuson Origin Diagnostic Ultrasound System |
| Janssen Pharmaceuticals, INC | $17.25 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Beckelman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.